Tuesday, January 22, 2013

FDA approves first skin patch to combat migraines

See on Scoop.it - Perspectives on Health

(HealthDay News) —A skin patch for the treatment of migraines, and the intense waves of nausea that often accompany these debilitating headaches, has been approved by the U.S. Food and Drug Administration.

Stewart-Marshall’s insight:

The patch is attached to the upper arm or thigh, and when the patient pushes a button the drug is delivered through the skin. Zecuity, which is battery-operated, delivers 6.5 milligrams of sumatriptan over the course of about five hours and can relieve nausea, as well as reduce sensitivity to light and sound. NuPathe Inc., which makes Zecuity, hopes to have the patch on the market later this year.

See on medicalxpress.com

via Tumblr FDA approves first skin patch to combat migraines

Online Masters and PhDs

Online and Distance Learning